ask="1.880"
ask_size="2000"
average_daily_volume="283389"
bid="1.690"
bid_size="100"
book_value="0.436"
change="-0.065"
change_from_200_day_moving_average="-0.103"
change_from_50_day_moving_average="-0.115"
change_from_52_week_high="-1.245"
change_From_52_week_low="0.975"
change_in_percent="-3.495%"
close="1.795"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.095"
ebitda="-24.72M"
eps_estimate_current_year="-1.130"
eps_estimate_next_quarter="-0.290"
eps_estimate_next_year="-1.070"
ex_dividend_date="N/A"
float_shares="21469000"
high="1.890"
high_52_weeks="3.040"
last_trade_date="1/18/2017"
last_trade_price="1.795"
last_trade_size="167"
last_trade_time="4:00pm"
low="1.720"
low_52_weeks="0.820"
market_capitalization="42.09M"
moving_average_200_day="1.898"
moving_average_50_day="1.910"
name="CymaBay Therapeutics Inc."
notes="N/A"
one_year_target_price="6.750"
open="1.860"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-5.438%"
percent_change_from_50_day_moving_average="-6.027%"
percent_change_from_52_week_high="-40.954%"
percent_change_from_52_week_low="+118.876%"
previous_close="1.860"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.266"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="23447000"
short_ratio="2.980"
stock_exchange="NCM"
symbol="CBAY"
volume="80802"
weeks_range_52="0.820 - 3.040"
